Fmoc-N-(tert-butyloxycarbonylmethyl)glycine, 95%, 1g

N-(2,4-dimethoxybenzyl)-2-oxo-N-(1,2,4-thiadiazol-5-yl)-2,3-dihydrobenzo[d]oxazole-6-sulfonamide, 95%, 25g

5-Methylbenzofuran-2-carboxylic acid, 95.0%, 100mg

(4-Chloro-5-methylpyridin-2-yl)methanol, 95+%, 500mg

5,6-Dimethylpyridin-3-amine, 95.0%, 5g

Pyridin-3-ylacetic acid hydrochloride, 95.0%, 25g

3-Fluoro-5-methylbenzamide, 250mg

Óxido de lantano(III), 99,99%, pa, 50 g, envase de plástico.

4-Bromopyridine Hydrochloride>98.0%(T)5g

N-ethyl-2-(5-methyl-1H-benzimidazol-2-yl)ethanamine hydrochloride, 95.0%, 1g

6-(2-Aminothiazol-4-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one hydrochloride, 95.0%, 250mg

4,6-Dichloro-1H-indole, 97.0%, 5g

(R)-2-Benzylmorpholine, 97%, 200mg